There are several findings on ERBB2 gene amplification, also commonly known as member of the epidermal growth factor receptor family, in multiple tumor types including early endometroid uterine cancer (Kandoth et al., 2013; Abdel Azim et al., 2017) and ovarian cancer (Luo et al., 2018). This evidence concerns the gene EGFR and ovarian cancer.